Thorac Cardiovasc Surg 2013; 61(03): 246-250
DOI: 10.1055/s-0032-1322627
Original Thoracic
Georg Thieme Verlag KG Stuttgart · New York

Timing of Heparin and Thrombus Formation in Donor Lungs after Cardiac Death

Hari B. Keshava
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Carol F. Farver
2   Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, United States
,
Chase R. Brown
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Alexis E. Shafii
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Sudish C. Murthy
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
James J. Yun
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Nakul Vakil
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
Gosta B. Pettersson
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
,
David Park Mason
1   Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio, United States
› Author Affiliations
Further Information

Publication History

27 May 2012

27 June 2012

Publication Date:
03 December 2012 (online)

Abstract

Background Heparin is routinely administered to brain-dead donors before cardiac arrest, although it is not universally allowed for donation after cardiac death (DCD) donors due to concerns that death may be hastened. The lack of heparin may lead to thrombosis and compromised graft function. We evaluated the impact of timing of heparin administration and thrombi formation in a DCD pig model.

Methods Eight domestic adult pigs were administered systemic heparin (30,000 IU): four prior to cardiac arrest through intravenous injection (prearrest heparin) and four after cardiac arrest via injection into the right atrium followed by open cardiac massage (postarrest heparin). Pigs were euthanized with potassium chloride and a minimum of 5 minutes of cardiac silence allowed before organ procurement. Lungs were flushed with antegrade and retrograde Perfadex, and pulmonary preservation solution effluent was evaluated for gross thrombi. Organs were fixed in formalin, sagittally sectioned, and evaluated by a pulmonary pathologist blinded to treatment.

Results Antegrade and retrograde flushes demonstrated no significant thrombi. Gross pathologic evaluation revealed no occlusive central thrombi. Scant peripheral thrombi were detected in both treatment groups. No microscopic thrombi were noted in either treatment group.

Conclusions Delayed heparin administration after cardiac death does not affect thrombus formation in an animal model of lung procurement after cardiac death. Concern about clinically significant thrombosis occurring when heparin is not given before cardiac arrest appears unfounded. These findings suggest that DCD lungs can be used regardless of antemortem heparin administration.

 
  • References

  • 1 Heron M. Deaths: leading causes for 2007. Natl Vital Stat Rep 2011; 59 (8) 1-95
  • 2 Snoeijs MGJ, Winkens B, Heemskerk MBA , et al. Kidney transplantation from donors after cardiac death: a 25-year experience. Transplantation 2010; 90 (10) 1106-1112
  • 3 Nguyen JH, Bonatti H, Dickson RC , et al. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant 2009; 23 (2) 168-173
  • 4 Lee JC, Christie JD. Primary graft dysfunction. Clin Chest Med 2011; 32 (2) 279-293
  • 5 Christie JD, Kotloff RM, Pochettino A , et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124 (4) 1232-1241
  • 6 Snell GI, Westall GP. Selection and management of the lung donor. Clin Chest Med 2011; 32 (2) 223-232
  • 7 Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995; 27 (5) 2893-2894
  • 8 Botha P, Trivedi D, Weir CJ , et al. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg 2006; 131 (5) 1154-1160
  • 9 de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167 (4) 490-511
  • 10 National Research Council. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: The National Academies Press; 2011
  • 11 Mason DP, Thuita L, Alster JM , et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg 2008; 136 (4) 1061-1066
  • 12 Hardy JD, Webb WR, Dalton Jr ML, Walker Jr GR. Lung homotransplantation in man. JAMA 1963; 186 (12) 1065-1074
  • 13 Mason DP, Murthy SC, Gonzalez-Stawinski GV , et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant 2008; 27 (5) 561-563
  • 14 De Oliveira NC, Osaki S, Maloney JD , et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010; 139 (5) 1306-1315
  • 15 De Vleeschauwer SI, Wauters S, Dupont LJ , et al. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. J Heart Lung Transplant 2011; 30 (9) 975-981
  • 16 Erasmus ME, Verschuuren EAM, Nijkamp DM, Vermeyden JW, van der Bij W. Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report. Transplantation 2010; 89 (4) 452-457
  • 17 Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J Heart Lung Transplant 2008; 27 (1) 78-85
  • 18 Oto T, Rabinov M, Griffiths AP , et al. Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: a major mechanism of primary graft failure?. J Thorac Cardiovasc Surg 2005; 130 (5) 1446
  • 19 Izbicki G, Bairey O, Shitrit D, Lahav J, Kramer MR. Increased thromboembolic events after lung transplantation. Chest 2006; 129 (2) 412-416
  • 20 Ware LB, Fang X, Wang Y, Babcock WD, Jones K, Matthay MA. High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation. J Heart Lung Transplant 2005; 24 (10) 1650-1656
  • 21 Van De Wauwer C, Neyrinck AP, Geudens N , et al. Retrograde flush following topical cooling is superior to preserve the non-heart-beating donor lung. Eur J Cardiothorac Surg 2007; 31 (6) 1125-1132 , discussion 1132–1133
  • 22 Hayama M, Date H, Oto T, Aoe M, Andou A, Shimizu N. Improved lung function by means of retrograde flush in canine lung transplantation with non-heart-beating donors. J Thorac Cardiovasc Surg 2003; 125 (4) 901-906
  • 23 Van De Wauwer C, Neyrinck AP, Geudens N , et al. Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion. J Surg Res 2009; 154 (1) 118-125
  • 24 Okazaki M, Date H, Inokawa H , et al. Optimal time for post-mortem heparinization in canine lung transplantation with non-heart-beating donors. J Heart Lung Transplant 2006; 25 (4) 454-460
  • 25 Inokawa H, Date H, Okazaki M , et al. Effects of postmortem heparinization in canine lung transplantation with non-heart-beating donors. J Thorac Cardiovasc Surg 2005; 129 (2) 429-434
  • 26 Roussi J, André P, Samama M , et al. Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia. Thromb Res 1996; 81 (3) 297-305
  • 27 Miyoshi K, Oto T, Otani S , et al. Effect of donor pre-mortem hypoxia and hypotension on graft function and start of warm ischemia in donation after cardiac death lung transplantation. J Heart Lung Transplant 2011; 30 (4) 445-451